TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2743937
log Bayes Factor = 18.6559
Chromosome 6   position 29,807,923  (GRCh37) Explore rs2743937 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
L40.5 Arthropathic psoriasis
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
L40 Psoriasis
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
0.000 0.010 0.990
E83 Disorders of mineral metabolism
0.000 0.098 0.902
E70-E90 Metabolic disorders
0.000 0.105 0.895
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.106 0.894
E89.0 Postprocedural hypothyroidism
0.000 0.108 0.892
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.128 0.872
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.133 0.867
E00-E07 Disorders of thyroid gland
0.000 0.134 0.866
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.137 0.863
E05.9 Thyrotoxicosis, unspecified
0.000 0.137 0.863
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.146 0.854
L40.8 Other psoriasis
0.000 0.147 0.852
E16 Other disorders of pancreatic internal secretion
0.000 0.155 0.845
E16.2 Hypoglycaemia, unspecified
0.000 0.157 0.843
E85 Amyloidosis
0.000 0.193 0.807
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.238 0.762
E89.2 Postprocedural hypoparathyroidism
0.000 0.241 0.759
L40.3 Pustulosis palmaris et plantaris
0.000 0.283 0.717
L40.2 Acrodermatitis continua
0.000 0.283 0.717
L40.1 Generalised pustular psoriasis
0.000 0.283 0.717
E03 Other hypothyroidism
0.000 0.285 0.715
E85.9 Amyloidosis, unspecified
0.000 0.319 0.681
L40.4 Guttate psoriasis
0.000 0.328 0.672
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.331 0.669
E85.4 Organ-limited amyloidosis
0.000 0.331 0.669
E80.4 Gilbert's syndrome
0.000 0.334 0.666
E89.3 Postprocedural hypopituitarism
0.000 0.347 0.653
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.353 0.647
E83.8 Other disorders of mineral metabolism
0.000 0.353 0.647
E83.2 Disorders of zinc metabolism
0.000 0.353 0.647
E83.0 Disorders of copper metabolism
0.000 0.353 0.647
E03.9 Hypothyroidism, unspecified
0.000 0.354 0.646
E84 Cystic fibrosis
0.000 0.358 0.642
E79 Disorders of purine and pyrimidine metabolism
0.000 0.358 0.642
E77 Disorders of glycoprotein metabolism
0.000 0.358 0.642
E76 Disorders of glycosaminoglycan metabolism
0.000 0.358 0.642
E72 Other disorders of amino-acid metabolism
0.000 0.358 0.642
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.358 0.642
E70 Disorders of aromatic amino-acid metabolism
0.000 0.358 0.642
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.358 0.642
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.359 0.641
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.359 0.641
E89.5 Postprocedural testicular hypofunction
0.000 0.359 0.641
E89.1 Postprocedural hypoinsulinaemia
0.000 0.359 0.641
E89.4 Postprocedural ovarian failure
0.000 0.361 0.639
L40.0 Psoriasis vulgaris
0.000 0.361 0.639
E05.8 Other thyrotoxicosis
0.000 0.373 0.627
E05.5 Thyroid crisis or storm
0.000 0.375 0.625
E05.4 Thyrotoxicosis factitia
0.000 0.375 0.625
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.375 0.625
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.375 0.625
E74 Other disorders of carbohydrate metabolism
0.000 0.377 0.623
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.379 0.621
E00 Congenital iodine-deficiency syndrome
0.000 0.379 0.621
E85.3 Secondary systemic amyloidosis
0.000 0.382 0.618
E73 Lactose intolerance
0.000 0.384 0.616
E15 Nondiabetic hypoglycaemic coma
0.000 0.388 0.612
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.394 0.606
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.394 0.606
E16.4 Abnormal secretion of gastrin
0.000 0.394 0.606
E16.3 Increased secretion of glucagon
0.000 0.394 0.606
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.399 0.601
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.400 0.600
E06 Thyroiditis
0.000 0.401 0.599
E85.8 Other amyloidosis
0.000 0.421 0.578
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.421 0.578
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.421 0.578
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.421 0.578
E03.8 Other specified hypothyroidism
0.000 0.441 0.559
E83.3 Disorders of phosphorus metabolism
0.000 0.443 0.557
E80.6 Other disorders of bilirubin metabolism
0.000 0.446 0.554
E16.1 Other hypoglycaemia
0.000 0.447 0.553
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.447 0.553
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.453 0.546
E80.5 Crigler-Najjar syndrome
0.000 0.453 0.546
E80.3 Defects of catalase and peroxydase
0.000 0.453 0.546
E80.1 Porphyria cutanea tarda
0.000 0.453 0.546
E80.0 Hereditary erythropoietic porphyria
0.000 0.453 0.546
E80.2 Other porphyria
0.000 0.458 0.542
E40-E46 Malnutrition
0.000 0.460 0.539
E03.5 Myxoedema coma
0.000 0.487 0.513
E03.4 Atrophy of thyroid (acquired)
0.000 0.487 0.513
E03.3 Postinfectious hypothyroidism
0.000 0.487 0.513
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.487 0.513
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.509 0.491
K90 Intestinal malabsorption
0.000 0.526 0.474
E03.1 Congenital hypothyroidism without goitre
0.000 0.530 0.470
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.540 0.460
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.540 0.460
E70.3 Albinism
0.000 0.540 0.460
E70.2 Disorders of tyrosine metabolism
0.000 0.540 0.460
E70.1 Other hyperphenylalaninaemias
0.000 0.540 0.460
E70.0 Classical phenylketonuria
0.000 0.540 0.460
E71.3 Disorders of fatty-acid metabolism
0.000 0.540 0.460
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.540 0.460
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.540 0.460
E71.0 Maple-syrup-urine disease
0.000 0.540 0.460
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.540 0.460
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.540 0.460
E72.5 Disorders of glycine metabolism
0.000 0.540 0.460
E72.4 Disorders of ornithine metabolism
0.000 0.540 0.460
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.540 0.460
E72.2 Disorders of urea cycle metabolism
0.000 0.540 0.460
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.540 0.460
E72.0 Disorders of amino-acid transport
0.000 0.540 0.460
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.540 0.460
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.540 0.460
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.540 0.460
E76.2 Other mucopolysaccharidoses
0.000 0.540 0.460
E76.1 Mucopolysaccharidosis, type II
0.000 0.540 0.460
E76.0 Mucopolysaccharidosis, type I
0.000 0.540 0.460
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.540 0.460
E77.8 Other disorders of glycoprotein metabolism
0.000 0.540 0.460
E77.1 Defects in glycoprotein degradation
0.000 0.540 0.460
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.540 0.460
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.540 0.460
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.540 0.460
E79.1 Lesch-Nyhan syndrome
0.000 0.540 0.460
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.540 0.460
E84.9 Cystic fibrosis, unspecified
0.000 0.540 0.460
E84.8 Cystic fibrosis with other manifestations
0.000 0.540 0.460
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.540 0.460
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.540 0.460
E07 Other disorders of thyroid
0.000 0.547 0.452
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.553 0.447
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.553 0.447
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.553 0.447
E74.2 Disorders of galactose metabolism
0.000 0.553 0.447
E74.1 Disorders of fructose metabolism
0.000 0.553 0.447
E74.0 Glycogen storage disease
0.000 0.553 0.447
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.555 0.445
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.555 0.445
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.555 0.445
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.555 0.445
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.555 0.445
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.555 0.445
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.555 0.445
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.555 0.445
E06.9 Thyroiditis, unspecified
0.000 0.557 0.443
E73.8 Other lactose intolerance
0.000 0.558 0.442
E73.1 Secondary lactase deficiency
0.000 0.558 0.442
E73.0 Congenital lactase deficiency
0.000 0.558 0.442
E65-E68 Obesity and other hyperalimentation
0.000 0.565 0.435
E75.6 Lipid storage disorder, unspecified
0.000 0.569 0.431
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.569 0.431
E75.3 Sphingolipidosis, unspecified
0.000 0.569 0.431
E75.2 Other sphingolipidosis
0.000 0.569 0.431
E75.1 Other gangliosidosis
0.000 0.569 0.431
E75.0 GM2 gangliosidosis
0.000 0.569 0.431
E06.4 Drug-induced thyroiditis
0.000 0.571 0.429
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.571 0.429
E06.1 Subacute thyroiditis
0.000 0.571 0.429
E06.0 Acute thyroiditis
0.000 0.571 0.429
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.571 0.429
K90.9 Intestinal malabsorption, unspecified
0.000 0.583 0.417
E73.9 Lactose intolerance, unspecified
0.000 0.584 0.416
E06.3 Autoimmune thyroiditis
0.000 0.587 0.412
E06.5 Other chronic thyroiditis
0.000 0.590 0.410
E88 Other metabolic disorders
0.000 0.593 0.406
E75.5 Other lipid storage disorders
0.000 0.610 0.389
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.613 0.387
E45 Retarded development following protein-energy malnutrition
0.000 0.613 0.387
E43 Unspecified severe protein-energy malnutrition
0.000 0.613 0.387
E42 Marasmic kwashiorkor
0.000 0.613 0.387
E41 Nutritional marasmus
0.000 0.613 0.387
E40 Kwashiorkor
0.000 0.613 0.387
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.622 0.378
E83.4 Disorders of magnesium metabolism
0.000 0.637 0.363
L40-L45 Papulosquamous disorders
0.000 0.637 0.363
E50-E64 Other nutritional deficiencies
0.000 0.639 0.360
E10-E14 Diabetes mellitus
0.000 0.657 0.343
K90.3 Pancreatic steatorrhoea
0.000 0.660 0.340
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.660 0.340
K90.1 Tropical sprue
0.000 0.660 0.340
E07.1 Dyshormogenetic goitre
0.000 0.675 0.324
E07.0 Hypersecretion of calcitonin
0.000 0.675 0.324
E65 Localised adiposity
0.000 0.679 0.321
E67 Other hyperalimentation
0.000 0.688 0.312
E68 Sequelae of hyperalimentation
0.000 0.688 0.312
E46 Unspecified protein-energy malnutrition
0.000 0.695 0.305
K90.8 Other intestinal malabsorption
0.000 0.699 0.301
E88.9 Metabolic disorder, unspecified
0.000 0.708 0.292
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.716 0.284
E88.8 Other specified metabolic disorders
0.000 0.718 0.282
E07.9 Disorder of thyroid, unspecified
0.000 0.720 0.280
E88.3 Tumour lysis syndrome
0.000 0.722 0.278
E44.1 Mild protein-energy malnutrition
0.000 0.722 0.277
E44.0 Moderate protein-energy malnutrition
0.000 0.722 0.277
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.733 0.267
L44 Other papulosquamous disorders
0.000 0.740 0.260
L41 Parapsoriasis
0.000 0.740 0.260
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.740 0.260
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.741 0.258
E63 Other nutritional deficiencies
0.000 0.741 0.258
E56 Other vitamin deficiencies
0.000 0.741 0.258
E51 Thiamine deficiency
0.000 0.741 0.258
E50 Vitamin A deficiency
0.000 0.741 0.258
E60 Dietary zinc deficiency
0.000 0.741 0.258
E59 Dietary selenium deficiency
0.000 0.741 0.258
E58 Dietary calcium deficiency
0.000 0.741 0.258
E54 Ascorbic acid deficiency
0.000 0.741 0.258
E52 Niacin deficiency [pellagra]
0.000 0.741 0.258
L43 Lichen planus
0.000 0.747 0.253
E12 Malnutrition-related diabetes mellitus
0.000 0.754 0.246
E88.2 Lipomatosis, not elsewhere classified
0.000 0.756 0.243
E10 Insulin-dependent diabetes mellitus
0.000 0.762 0.238
L42 Pityriasis rosea
0.000 0.764 0.236
E07.8 Other specified disorders of thyroid
0.000 0.767 0.232
E67.8 Other specified hyperalimentation
0.000 0.776 0.224
E67.3 Hypervitaminosis D
0.000 0.776 0.224
E67.2 Megavitamin-B6 syndrome
0.000 0.776 0.224
E67.1 Hypercarotenaemia
0.000 0.776 0.224
E67.0 Hypervitaminosis A
0.000 0.776 0.224
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.783 0.216
E61 Deficiency of other nutrient elements
0.000 0.788 0.211
E11 Non-insulin-dependent diabetes mellitus
0.000 0.789 0.211
E10.1 With ketoacidosis
0.000 0.794 0.206
E53 Deficiency of other B group vitamins
0.000 0.794 0.205
E11.3 With ophthalmic complications
0.000 0.795 0.205
E04 Other non-toxic goitre
0.000 0.796 0.204
E83.5 Disorders of calcium metabolism
0.000 0.800 0.200
E13 Other specified diabetes mellitus
0.000 0.802 0.198
E55 Vitamin D deficiency
0.000 0.803 0.197
E10.4 With neurological complications
0.000 0.808 0.192
E10.6 With other specified complications
0.000 0.810 0.190
L43.9 Lichen planus, unspecified
0.000 0.811 0.189
L41.9 Parapsoriasis, unspecified
0.000 0.813 0.187
L41.8 Other parapsoriasis
0.000 0.813 0.187
L41.5 Retiform parapsoriasis
0.000 0.813 0.187
L41.4 Large plaque parapsoriasis
0.000 0.813 0.187
L41.3 Small plaque parapsoriasis
0.000 0.813 0.187
L41.2 Lymphomatoid papulosis
0.000 0.813 0.187
L41.1 Pityriasis lichenoides chronica
0.000 0.813 0.187
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.813 0.187
L44.9 Papulosquamous disorder, unspecified
0.000 0.813 0.187
L44.8 Other specified papulosquamous disorders
0.000 0.813 0.187
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.813 0.187
L44.3 Lichen ruber moniliformis
0.000 0.813 0.187
L44.2 Lichen striatus
0.000 0.813 0.187
L44.1 Lichen nitidus
0.000 0.813 0.187
L44.0 Pityriasis rubra pilaris
0.000 0.813 0.187
E50.9 Vitamin A deficiency, unspecified
0.000 0.814 0.185
E50.8 Other manifestations of vitamin A deficiency
0.000 0.814 0.185
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.814 0.185
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.814 0.185
E50.5 Vitamin A deficiency with night blindness
0.000 0.814 0.185
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.814 0.185
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.814 0.185
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.814 0.185
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.814 0.185
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.814 0.185
E51.9 Thiamine deficiency, unspecified
0.000 0.814 0.185
E51.8 Other manifestations of thiamine deficiency
0.000 0.814 0.185
E51.2 Wernicke's encephalopathy
0.000 0.814 0.185
E51.1 Beriberi
0.000 0.814 0.185
E56.9 Vitamin deficiency, unspecified
0.000 0.814 0.185
E56.8 Deficiency of other vitamins
0.000 0.814 0.185
E56.1 Deficiency of vitamin K
0.000 0.814 0.185
E56.0 Deficiency of vitamin E
0.000 0.814 0.185
E63.9 Nutritional deficiency, unspecified
0.000 0.814 0.185
E63.8 Other specified nutritional deficiencies
0.000 0.814 0.185
E63.1 Imbalance of constituents of food intake
0.000 0.814 0.185
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.814 0.185
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.814 0.185
E64.8 Sequelae of other nutritional deficiencies
0.000 0.814 0.185
E64.3 Sequelae of rickets
0.000 0.814 0.185
E64.2 Sequelae of vitamin C deficiency
0.000 0.814 0.185
E64.1 Sequelae of vitamin A deficiency
0.000 0.814 0.185
E64.0 Sequelae of protein-energy malnutrition
0.000 0.814 0.185
L43.3 Subacute (active) lichen planus
0.000 0.818 0.181
L43.2 Lichenoid drug reaction
0.000 0.818 0.181
L43.1 Bullous lichen planus
0.000 0.818 0.181
L43.0 Hypertrophic lichen planus
0.000 0.818 0.181
E10.5 With peripheral circulatory complications
0.000 0.822 0.178
E12.9 Without complications
0.000 0.823 0.177
E12.8 With unspecified complications
0.000 0.823 0.177
E12.7 With multiple complications
0.000 0.823 0.177
E12.6 With other specified complications
0.000 0.823 0.177
E12.5 With peripheral circulatory complications
0.000 0.823 0.177
E12.4 With neurological complications
0.000 0.823 0.177
E12.3 With ophthalmic complications
0.000 0.823 0.177
E12.2 With renal complications
0.000 0.823 0.177
E12.1 With ketoacidosis
0.000 0.823 0.177
E12.0 With coma
0.000 0.823 0.177
E10.2 With renal complications
0.000 0.826 0.174
E14 Unspecified diabetes mellitus
0.000 0.828 0.172
E11.5 With peripheral circulatory complications
0.000 0.828 0.172
E10.7 With multiple complications
0.000 0.829 0.171
E10.0 With coma
0.000 0.829 0.170
L43.8 Other lichen planus
0.000 0.835 0.165
E11.1 With ketoacidosis
0.000 0.835 0.165
E10.8 With unspecified complications
0.000 0.838 0.162
E53.9 Vitamin B deficiency, unspecified
0.000 0.847 0.152
E61.9 Deficiency of nutrient element, unspecified
0.000 0.848 0.152
E61.8 Deficiency of other specified nutrient elements
0.000 0.848 0.152
E61.7 Deficiency of multiple nutrient elements
0.000 0.848 0.152
E61.6 Vanadium deficiency
0.000 0.848 0.152
E61.5 Molybdenum deficiency
0.000 0.848 0.152
E61.4 Chromium deficiency
0.000 0.848 0.152
E61.3 Manganese deficiency
0.000 0.848 0.152
E61.2 Magnesium deficiency
0.000 0.848 0.152
E61.0 Copper deficiency
0.000 0.848 0.152
E11.7 With multiple complications
0.000 0.848 0.152
E04.0 Non-toxic diffuse goitre
0.000 0.851 0.149
E53.1 Pyridoxine deficiency
0.000 0.852 0.147
E53.0 Riboflavin deficiency
0.000 0.852 0.147
E04.8 Other specified non-toxic goitre
0.000 0.854 0.146
E14.3 With ophthalmic complications
0.000 0.857 0.143
E13.8 With unspecified complications
0.000 0.858 0.142
E13.7 With multiple complications
0.000 0.858 0.142
E13.6 With other specified complications
0.000 0.858 0.142
E13.5 With peripheral circulatory complications
0.000 0.858 0.142
E13.4 With neurological complications
0.000 0.858 0.142
E13.3 With ophthalmic complications
0.000 0.858 0.142
E13.2 With renal complications
0.000 0.858 0.142
E13.1 With ketoacidosis
0.000 0.858 0.142
E13.0 With coma
0.000 0.858 0.142
E55.0 Rickets, active
0.000 0.858 0.141
E11.8 With unspecified complications
0.000 0.859 0.141
E10.3 With ophthalmic complications
0.000 0.867 0.133
E14.8 With unspecified complications
0.000 0.871 0.128
E11.4 With neurological complications
0.000 0.873 0.127
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.875 0.125
E14.4 With neurological complications
0.000 0.876 0.124
E14.7 With multiple complications
0.000 0.876 0.124
E14.6 With other specified complications
0.000 0.876 0.124
E14.0 With coma
0.000 0.876 0.124
E14.1 With ketoacidosis
0.000 0.877 0.123
E14.5 With peripheral circulatory complications
0.000 0.877 0.123
E11.0 With coma
0.000 0.879 0.121
E04.9 Non-toxic goitre, unspecified
0.000 0.881 0.118
E11.6 With other specified complications
0.000 0.882 0.118
E14.2 Withrenal complications
0.000 0.892 0.108
E61.1 Iron deficiency
0.000 0.895 0.104
E11.2 With renal complications
0.000 0.898 0.102
E66 Obesity
0.000 0.899 0.101
E78.8 Other disorders of lipoprotein metabolism
0.000 0.899 0.101
E78.6 Lipoprotein deficiency
0.000 0.904 0.096
E13.9 Without complications
0.000 0.906 0.094
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.910 0.090
E78.3 Hyperchylomicronaemia
0.000 0.910 0.090
E78.4 Other hyperlipidaemia
0.000 0.913 0.087
E53.8 Deficiency of other specified B group vitamins
0.000 0.916 0.084
E55.9 Vitamin D deficiency, unspecified
0.000 0.920 0.080
E04.1 Non-toxic single thyroid nodule
0.000 0.921 0.079
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.923 0.077
E66.1 Drug-induced obesity
0.000 0.927 0.073
E78.1 Pure hyperglyceridaemia
0.000 0.931 0.069
E78.2 Mixed hyperlipidaemia
0.000 0.931 0.069
E66.0 Obesity due to excess calories
0.000 0.937 0.063
E04.2 Non-toxic multinodular goitre
0.000 0.953 0.047
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.957 0.043
E66.8 Other obesity
0.000 0.958 0.041
E20-E35 Disorders of other endocrine glands
0.000 0.960 0.040
M07.3 Other psoriatic arthropathies
0.000 0.962 0.038
E10.9 Without complications
0.000 0.964 0.036
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.966 0.034
K90-K93 Other diseases of the digestive system
0.000 0.968 0.032
E34 Other endocrine disorders
0.000 0.968 0.031
M07 Psoriatic and enteropathic arthropathies
0.000 0.969 0.031
E34.9 Endocrine disorder, unspecified
0.000 0.971 0.029
M06.9 Rheumatoid arthritis, unspecified
0.000 0.971 0.029
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.971 0.028
E32 Diseases of thymus
0.000 0.971 0.028
E31 Polyglandular dysfunction
0.000 0.971 0.028
E30 Disorders of puberty, not elsewhere classified
0.000 0.971 0.028
M07.34 Other psoriatic arthropathies (Hand)
0.000 0.971 0.029
M07.30 Other psoriatic arthropathies (Multiple sites)
0.000 0.971 0.029
M07.36 Other psoriatic arthropathies (Lower leg)
0.000 0.971 0.028
E26 Hyperaldosteronism
0.000 0.972 0.028
M06 Other rheumatoid arthritis
0.000 0.972 0.028
E20 Hypoparathyroidism
0.000 0.972 0.027
E24 Cushing's syndrome
0.000 0.973 0.027
M07.38 Other psoriatic arthropathies (Other)
0.000 0.973 0.027
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.000 0.973 0.027
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.000 0.973 0.027
M07.33 Other psoriatic arthropathies (Forearm)
0.000 0.973 0.027
M07.32 Other psoriatic arthropathies (Upper arm)
0.000 0.973 0.027
M07.31 Other psoriatic arthropathies (Shoulder region)
0.000 0.973 0.027
E25 Adrenogenital disorders
0.001 0.973 0.027
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.974 0.026
M05-M14 Inflammatory polyarthropathies
0.000 0.974 0.026
E29 Testicular dysfunction
0.000 0.975 0.025
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.975 0.025
M06.3 Rheumatoid nodule
0.000 0.976 0.024
K93 Disorders of other digestive organs in diseases classified elsewhere
0.000 0.977 0.023
E34.5 Androgen resistance syndrome
0.000 0.977 0.023
E34.4 Constitutional tall stature
0.000 0.977 0.023
E34.3 Short stature, not elsewhere classified
0.000 0.977 0.023
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.977 0.023
E34.1 Other hypersecretion of intestinal hormones
0.000 0.977 0.023
E28 Ovarian dysfunction
0.001 0.977 0.022
M07.6 Other enteropathic arthropathies
0.000 0.978 0.022
M07.5 Arthropathy in ulcerative colitis
0.000 0.978 0.022
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.000 0.978 0.022
M07.2 Psoriatic spondylitis
0.000 0.978 0.022
M07.1 Arthritis mutilans
0.000 0.978 0.022
M07.0 Distal interphalangeal psoriatic arthropathy
0.000 0.978 0.022
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.978 0.022
E30.9 Disorder of puberty, unspecified
0.000 0.979 0.021
E30.8 Other disorders of puberty
0.000 0.979 0.021
E30.1 Precocious puberty
0.000 0.979 0.021
E30.0 Delayed puberty
0.000 0.979 0.021
E31.9 Polyglandular dysfunction, unspecified
0.000 0.979 0.021
E31.8 Other polyglandular dysfunction
0.000 0.979 0.021
E31.1 Polyglandular hyperfunction
0.000 0.979 0.021
E31.0 Autoimmune polyglandular failure
0.000 0.979 0.021
E32.9 Disease of thymus, unspecified
0.000 0.979 0.021
E32.8 Other diseases of thymus
0.000 0.979 0.021
E32.1 Abscess of thymus
0.000 0.979 0.021
E32.0 Persistent hyperplasia of thymus
0.000 0.979 0.021
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.979 0.021
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.979 0.021
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.979 0.021
M06.4 Inflammatory polyarthropathy
0.000 0.979 0.021
M05 Seropositive rheumatoid arthritis
0.000 0.979 0.021
E26.9 Hyperaldosteronism, unspecified
0.000 0.979 0.020
E26.8 Other hyperaldosteronism
0.000 0.979 0.020
E26.1 Secondary hyperaldosteronism
0.000 0.979 0.020
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.979 0.020
E34.0 Carcinoid syndrome
0.000 0.980 0.020
M06.8 Other specified rheumatoid arthritis
0.000 0.980 0.020
M06.2 Rheumatoid bursitis
0.000 0.980 0.020
M06.1 Adult-onset Still's disease
0.000 0.980 0.020
E24.9 Cushing's syndrome, unspecified
0.000 0.980 0.020
E20.8 Other hypoparathyroidism
0.000 0.980 0.020
E20.1 Pseudohypoparathyroidism
0.000 0.980 0.020
E20.0 Idiopathic hypoparathyroidism
0.000 0.980 0.020
E24.8 Other Cushing's syndrome
0.000 0.980 0.019
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.980 0.019
E24.3 Ectopic ACTH syndrome
0.000 0.980 0.019
E24.1 Nelson's syndrome
0.000 0.980 0.019
E26.0 Primary hyperaldosteronism
0.000 0.980 0.019
E25.9 Adrenogenital disorder, unspecified
0.001 0.980 0.019
E25.8 Other adrenogenital disorders
0.001 0.980 0.019
M06.34 Rheumatoid nodule (Hand)
0.000 0.980 0.020
M10 Gout
0.000 0.980 0.020
E27 Other disorders of adrenal gland
0.000 0.981 0.019
E22 Hyperfunction of pituitary gland
0.001 0.981 0.019
E34.8 Other specified endocrine disorders
0.000 0.981 0.019
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.981 0.019
E24.0 Pituitary-dependent Cushing's disease
0.000 0.981 0.019
M06.0 Seronegative rheumatoid arthritis
0.000 0.981 0.019
M12 Other specific arthropathies
0.000 0.981 0.019
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.981 0.019
E24.2 Drug-induced Cushing's syndrome
0.000 0.981 0.018
M09 Juvenile arthritis in diseases classified elsewhere
0.000 0.981 0.019
M08 Juvenile arthritis
0.000 0.981 0.019
E20.9 Hypoparathyroidism, unspecified
0.000 0.981 0.018
E29.9 Testicular dysfunction, unspecified
0.000 0.982 0.018
E29.8 Other testicular dysfunction
0.000 0.982 0.018
E29.0 Testicular hyperfunction
0.000 0.982 0.018
E78.5 Hyperlipidaemia, unspecified
0.000 0.982 0.018
E28.3 Primary ovarian failure
0.001 0.982 0.017
M14 Arthropathies in other diseases classified elsewhere
0.000 0.982 0.018
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.982 0.018
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.982 0.018
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.001 0.982 0.017
N42.1 Congestion and haemorrhage of prostate
0.018 0.982 0.000
M05.9 Seropositive rheumatoid arthritis, unspecified
0.000 0.982 0.018
M06.37 Rheumatoid nodule (Ankle and foot)
0.000 0.982 0.017
M11 Other crystal arthropathies
0.000 0.982 0.017
E86 Volume depletion
0.000 0.982 0.017
M06.39 Rheumatoid nodule (Site unspecified)
0.000 0.983 0.017
M06.38 Rheumatoid nodule (Other)
0.000 0.983 0.017
M06.36 Rheumatoid nodule (Lower leg)
0.000 0.983 0.017
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.000 0.983 0.017
M06.33 Rheumatoid nodule (Forearm)
0.000 0.983 0.017
M06.31 Rheumatoid nodule (Shoulder region)
0.000 0.983 0.017
M06.30 Rheumatoid nodule (Multiple sites)
0.000 0.983 0.017
Chapter XII Diseases of the skin and subcutaneous tissue
0.000 0.983 0.017
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.000 0.983 0.017
K93.1 Megacolon in Chagas' disease
0.000 0.983 0.017
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.000 0.983 0.017
E28.9 Ovarian dysfunction, unspecified
0.001 0.983 0.016
E28.8 Other ovarian dysfunction
0.001 0.983 0.016
E28.1 Androgen excess
0.001 0.983 0.016
E28.0 Oestrogen excess
0.001 0.983 0.016
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.984 0.016
L20-L30 Dermatitis and eczema
0.000 0.984 0.016
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.000 0.984 0.016
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.000 0.984 0.016
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.000 0.984 0.016
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.000 0.984 0.016
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.000 0.984 0.016
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.000 0.984 0.016
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.000 0.984 0.016
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.000 0.984 0.016
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.000 0.984 0.016
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.000 0.984 0.016
M07.19 Arthritis mutilans (Site unspecified)
0.000 0.984 0.016
M07.18 Arthritis mutilans (Other)
0.000 0.984 0.016
M07.17 Arthritis mutilans (Ankle and foot)
0.000 0.984 0.016
M07.16 Arthritis mutilans (Lower leg)
0.000 0.984 0.016
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.000 0.984 0.016
M07.14 Arthritis mutilans (Hand)
0.000 0.984 0.016

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.